- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chugai Pharmaceutical Co., Ltd. (4519)
Chugai Pharmaceutical Co., Ltd. stock price live, this page displays TYO 4519 stock exchange data. View the 4519 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chugai Pharmaceutical Co., Ltd. real time stock price chart below.
What Is the Chugai Pharmaceutical Co., Ltd. Stock Price Today?
The Chugai Pharmaceutical Co., Ltd. stock price today is 8,591.0.
What Is the Stock Symbol for Chugai Pharmaceutical Co., Ltd.?
The stock ticker symbol for Chugai Pharmaceutical Co., Ltd. is 4519.
Is 4519 the Same as $4519?
$4519 is a common way to refer to the Chugai Pharmaceutical Co., Ltd. ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Chugai Pharmaceutical Co., Ltd. Trade On?
Chugai Pharmaceutical Co., Ltd. is listed and trades on the Tokyo stock exchange.
Is Chugai Pharmaceutical Co., Ltd. a Good Stock to Buy?
Determining whether Chugai Pharmaceutical Co., Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Chugai Pharmaceutical Co., Ltd. share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4519 quote. (ISIN: JP3519400000)
What Is the Chugai Pharmaceutical Co., Ltd. Stock Price Today?
The Chugai Pharmaceutical Co., Ltd. stock price today is 8,591.0.
What Is the Stock Symbol for Chugai Pharmaceutical Co., Ltd.?
The stock ticker symbol for Chugai Pharmaceutical Co., Ltd. is 4519.
Is 4519 the Same as $4519?
$4519 is a common way to refer to the Chugai Pharmaceutical Co., Ltd. ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Chugai Pharmaceutical Co., Ltd. Trade On?
Chugai Pharmaceutical Co., Ltd. is listed and trades on the Tokyo stock exchange.
Is Chugai Pharmaceutical Co., Ltd. a Good Stock to Buy?
Determining whether Chugai Pharmaceutical Co., Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Chugai Pharmaceutical Co., Ltd. share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4519 quote. (ISIN: JP3519400000)
Currency in JPY
8,591.0
-66.0(-0.76%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,583.0
8,777.0
52 wk Range
5,942.0
10,700.0
Earnings results expected in 8 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,583.08,777.0
52 wk Range
5,942.010,700.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4519 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
9,816.7
Upside
+14.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept, an immunosuppressant; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi, a spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, an anti VEGF/anti Ang-2 bispecific antibody. The company was formerly known as Chugai Shinyaku Shokai and changed its name to Chugai Pharmaceutical Co., Ltd. in January 1943. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding AG.
Chugai Pharmaceutical Co., Ltd. Earnings Call Summary for Q4/2025
- Chugai Pharmaceutical reported FY 2025 revenue of 1,257.9 billion yen (+7.5% YoY) and core operating profit of 623.2 billion yen (+12.1% YoY), achieving a record high operating margin of 49.5%.
- Despite strong financial performance, the stock fell 1.63% post-earnings, possibly due to the reduction in phase 1 projects from 21 to 15.
- Overseas sales surged 12.8% YoY to 605.4 billion yen, outpacing domestic sales growth of 2.5% (472.4 billion yen).
- The company forecasts FY 2026 revenues of 1,345 billion yen (+6.9%) and aims to launch one global product annually by 2030.
- CEO Okuda emphasized commitment to multi-modality drug development and leveraging AI to refine go/no-go decision-making processes.
Last Updated: 01/29/2026, 03:16 PM
Read Full TranscriptChugai Pharmaceutical investor slides for Q4/2025
Last Update: Jan 29, 2026
See full investor slides
Compare 4519 to Peers and Sector
Metrics to compare | 4519 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4519PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.8x | 18.3x | −0.5x | |
PEG Ratio | 2.72 | 0.08 | 0.00 | |
Price / Book | 7.0x | 1.8x | 2.6x | |
Price / LTM Sales | 11.3x | 2.3x | 3.2x | |
Upside (Analyst Target) | 9.7% | 4.5% | 45.7% | |
Fair Value Upside | Unlock | 12.7% | 4.8% | Unlock |
Analyst Ratings
9 Buy
5 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9,816.7
(+14.27% Upside)
Earnings
Latest Release
Jan 29, 2026
EPS / Forecast
78.03 / 74.39
Revenue / Forecast
346.3B / 324.14B
People Also Watch
FAQ
What Is the Chugai Pharmaceutical (4519) Stock Price Today?
The Chugai Pharmaceutical stock price today is 8,591.0 JPY.
What Stock Exchange Does Chugai Pharmaceutical Trade On?
Chugai Pharmaceutical is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Chugai Pharmaceutical?
The stock symbol for Chugai Pharmaceutical is "4519."
Does Chugai Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Chugai Pharmaceutical dividend yield is 2.48%.
What Is the Chugai Pharmaceutical Market Cap?
As of today, Chugai Pharmaceutical market cap is 14.21T JPY.
What Is Chugai Pharmaceutical's Earnings Per Share (TTM)?
The Chugai Pharmaceutical EPS (TTM) is 263.7.
When Is the Next Chugai Pharmaceutical Earnings Date?
Chugai Pharmaceutical will release its next earnings report on Apr 24, 2026.
From a Technical Analysis Perspective, Is 4519 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Chugai Pharmaceutical Stock Split?
Chugai Pharmaceutical has split 3 times.
How Many Employees Does Chugai Pharmaceutical Have?
Chugai Pharmaceutical has 5104 employees.
What is the current trading status of Chugai Pharmaceutical (4519)?
As of Apr 16, 2026, Chugai Pharmaceutical (4519) is trading at a price of 8,591.0 JPY, with a previous close of 8,657.0 JPY. The stock has fluctuated within a day range of 8,583.0 JPY to 8,777.0 JPY, while its 52-week range spans from 5,942.0 JPY to 10,700.0 JPY.
What Is Chugai Pharmaceutical (4519) Price Target According to Analysts?
The average 12-month price target for Chugai Pharmaceutical is 9,816.7 JPY, with a high estimate of 13300 JPY and a low estimate of 6400 JPY. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +14.27% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.